HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
B E Johnson Selected Research
B E Johnson Research Topics
Disease
10
Neoplasms (Cancer)
01/2022 - 03/2000
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2014 - 07/2000
6
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2014 - 07/2000
3
Lung Neoplasms (Lung Cancer)
12/2001 - 10/2000
1
COVID-19
01/2022
1
Infections
01/2022
1
Stomatitis
02/2014
1
Adenocarcinoma
11/2001
1
Carcinoma (Carcinomatosis)
11/2001
1
Dyspnea (Shortness of Breath)
01/2001
1
Disease Progression
07/2000
1
Brain Neoplasms (Brain Tumor)
07/2000
Drug/Important Bio-Agent (IBA)
2
Cisplatin (Platino)
FDA Link
Generic
02/2014 - 07/2000
2
Everolimus
FDA Link
02/2014 - 02/2014
2
Paclitaxel (Taxol)
FDA Link
Generic
12/2001 - 07/2000
2
DNA (Deoxyribonucleic Acid)
IBA
09/2000 - 03/2000
1
ErbB Receptors (EGF Receptor)
IBA
10/2014
1
vandetanib (ZD6474)
IBA
10/2014
1
Docetaxel (Taxotere)
FDA Link
10/2014
1
Proteins (Proteins, Gene)
FDA Link
10/2014
1
Biomarkers (Surrogate Marker)
IBA
10/2014
1
TOR Serine-Threonine Kinases
IBA
02/2014
1
Erlotinib Hydrochloride (CP 358,774)
FDA Link
02/2014
1
Etoposide (VP 16)
FDA Link
Generic
02/2014
1
tipifarnib (R115777)
IBA
08/2004
1
Transferases
IBA
08/2004
1
Oligonucleotides
IBA
11/2001
1
Messenger RNA (mRNA)
IBA
11/2001
1
Oxygen (Dioxygen)
IBA
01/2001
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2000
1
Genetic Markers (Genetic Marker)
IBA
09/2000
1
Tyrosine Kinase Inhibitors
IBA
07/2000
1
Stem Cell Factor
IBA
07/2000
1
Imatinib Mesylate (Gleevec)
FDA Link
07/2000
1
Phosphotransferases (Kinase)
IBA
07/2000
Therapy/Procedure
7
Therapeutics
01/2022 - 07/2000
3
Drug Therapy (Chemotherapy)
02/2001 - 10/2000
1
Cranial Irradiation
07/2000